Failure of children with asthma to respond to daily aspirin therapy
View abstract on PubMed
Summary
This summary is machine-generated.Long-term aspirin did not improve asthma in children who showed no immediate reaction. Aspirin therapy did not alter wheezing, bronchodilator use, or lung function in this study.
Area Of Science
- Pediatric Pulmonology
- Pharmacology
Background
- Aspirin and NSAIDs have complex effects on asthma.
- While adverse reactions are known, some studies suggest benefits.
Purpose Of The Study
- To investigate the long-term effects of aspirin in children with asthma who do not exhibit immediate responses to aspirin challenge.
Main Methods
- A 9-week, double-blind, placebo-controlled crossover study.
- Ten children with moderately severe asthma received aspirin or placebo.
- Evaluated wheezing, bronchodilator/prednisone use, and spirometry.
Main Results
- No significant differences in clinical asthma outcomes between aspirin and placebo periods.
- Serum thromboxane B2 levels were reduced with aspirin, confirming compliance.
- Inhibition of platelet cyclooxygenase did not alter asthma course.
Conclusions
- Long-term aspirin administration does not appear to modify the clinical course of asthma in children without immediate aspirin sensitivity.
- Targeting the platelet prostaglandin cyclooxygenase pathway may not be clinically beneficial for these asthmatic patients.